Onc Now
In this episode of Onc Now, Paolo Bironzo joins us to discuss the evolving landscape of thoracic oncology and the innovations transforming lung cancer care. From targeted therapies and immunotherapy selection to advances in mesothelioma treatment and molecular profiling, Bironzo shares insights into the challenges clinicians face today and the future of precision medicine. He also reflects on the importance of treatment de-escalation, the complexities of clinical trials, and offers advice for the next generation of oncologists.
Speaker bio:
Paolo Bironzo is an Assistant Professor in the Department of Oncology at the University of Torino, Italy. He is recognised for his expertise in thoracic malignancies, particularly lung cancer and mesothelioma, and has contributed extensively to clinical and translational research in these areas.
Timestamps:
00:00 – Introduction
00:51 – Inspiration Behind Thoracic Oncology
03:17 – Current Challenges in Lung Cancer
04:50 – Impact of Targeted Therapies
07:14 – Selecting Patients for Immunotherapy
08:04 – Advances in Mesothelioma Treatment
14:52 – Molecular Profiling in Thoracic Cancer
19:52 – Challenges in Lung Cancer Trials
22:05 – Predicting Immunotherapy Response Challenges
24:23 – Future of Precision Medicine
26:05 – Advice for Early-Career Oncologists
28:40 – Three Wishes for Cancer Therapy
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
